Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
09/2010
09/23/2010US20100240638 Organic Compounds and their uses
09/23/2010US20100240625 Ophthalmic Formulations of Cetirizine and Methods of Use
09/23/2010US20100240618 Substituted piperazines
09/23/2010US20100240617 Bicyclic sphingosine 1-phosphate analogs
09/23/2010US20100240606 Associations of xanthogenates and cyclodextrins, and their use
09/23/2010US20100240605 Novel immunotherapy strategy
09/23/2010US20100240603 Expression inhibitor of nuclear transcription factor ap-1 and pharmaceuticals and products using the same
09/23/2010US20100240591 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection
09/23/2010US20100240590 Peptides and related molecules that bind to tall-1
09/23/2010US20100240583 Soluble protein and utilization of the same
09/23/2010US20100239654 Vesicular phospholipid gels comprising proteinaceous substances
09/23/2010US20100239633 Immunoglobulin constant region fc receptor binding agents
09/23/2010US20100239631 Thiopyrimidine-based compounds and uses thereof
09/23/2010US20100239613 Attenuated ehrlichiosis vaccine
09/23/2010US20100239609 Formulation of Sugar Solutions for Continuous Ultracentrifugation for Virus Purification
09/23/2010US20100239608 PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS
09/23/2010US20100239605 Recombinant Rhinovirus Vectors
09/23/2010US20100239604 Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
09/23/2010US20100239600 Conjugate purification
09/23/2010US20100239599 Vaccine Peptide Combinations Against Cat Allergy
09/23/2010US20100239579 CD47 Related Compositions and Methods for Treating Immunological Diseases and Disorders
09/23/2010US20100239576 Amino ester derivatives, sailts thereof and methods of use
09/23/2010US20100239572 Methods for treating and preventing gi syndrome and graft versus host disease
09/23/2010US20100239571 CD30 Binding Agents and Uses Thereof
09/23/2010US20100239569 Method Of Treating Disorders Of The Cardiovascular System And A Pharmaceutical Agent
09/23/2010US20100239551 Compounds and compositions as channel activating protease inhibitors
09/23/2010US20100239548 Isolation and Identification of T Cells
09/23/2010US20100239546 Bacterial mediated tnf alpha gene silencing
09/23/2010US20100239531 Stable liquid interferon formulations
09/23/2010US20100239530 Ifnar2 mutants, their production and use
09/23/2010US20100239528 Treating or Ameliorating a Neuroinflammatory or Demyelinating Disorder with Prolactin and Interferon-Beta
09/23/2010US20100239523 Tlr modulators and methods for using the same
09/23/2010US20100236550 Dry-powder medicament
09/23/2010CA2755790A1 Vaccination methods
09/23/2010CA2755782A1 Biomarkers and uses thereof
09/23/2010CA2755697A1 Amide derivative
09/23/2010CA2755133A1 Selective and potent peptide inhibitors of kv1.3
09/22/2010EP2230308A1 Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof
09/22/2010EP2230307A1 Neutrokine alpha
09/22/2010EP2230299A1 Novel cytokine ZCYTOR17 ligand
09/22/2010EP2230232A1 Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as DHODH inhibitors
09/22/2010EP2229399A1 Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereof
09/22/2010EP2229377A1 5-alkyl/alkenyl-3-cyanopyridines as kinase inhibitors
09/22/2010EP2229376A1 Indole-substituted 3-cyanopyridines as kinase inhibitors
09/22/2010EP2091950B1 Oxadiazole derivatives as s1p1 receptor agonists
09/22/2010EP1809271B9 Use of (r)-(halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators
09/22/2010EP1618092B1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
09/22/2010EP1617803B1 Malonamides and malonamide derivatives as modulators of chemokine receptor activity
09/22/2010EP1450850B1 Method of administering a thymosin alpha 1 peptide
09/22/2010EP1401853B1 Modulators of pharmacological agents
09/22/2010CN201585758U Therapeutic massage mat adopting traditional Chinese medicine magnetotherapy
09/22/2010CN1947722B Blood sugar regulator used during user having meals and its preparation method
09/22/2010CN1943607B Chinese medicine composition for nourishing qi and yin and its preparing method
09/22/2010CN1852708B Human beta-defensin secretion promoter
09/22/2010CN1788001B 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
09/22/2010CN1658872B Antiallergic
09/22/2010CN101842490A Antigenic compositions and use of same in the targeted delivery of nucleic acids
09/22/2010CN101842362A Benzothiazole compounds
09/22/2010CN101842113A Immune response inducer
09/22/2010CN101838601A Wallich wedelia herb health-care yellow wine
09/22/2010CN101838327A Human IL-15 subtype protein and preparation method and application thereof
09/22/2010CN101838307A K2 polypeptide synthesis product and application thereof
09/22/2010CN101838306A K4 polypeptide synthesis product and application thereof
09/22/2010CN101838305A T2 peptide synthesis product and application thereof
09/22/2010CN101838261A Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
09/22/2010CN101838202A Total terpenoids of ferula dissecta as well as medical application and preparation method thereof
09/22/2010CN101837091A Process for continuously extracting polygonatum saponin and polygonatum polysaccharose
09/22/2010CN101837087A Chinese medicinal composition for improving immunity, resisting fatigue and improving sexual function
09/22/2010CN101837079A Anti-inflammatory analgesic or anti-inflammatory immune medicinal composition, preparation method and application thereof
09/22/2010CN101837066A Application of golden thread detoxication decoction as compound preparation in preparing IOD active medicaments
09/22/2010CN101837065A Medicine with anti-hepatitis, anti-tumour and organism immunity improving functions and preparation method thereof
09/22/2010CN101837052A Herba saussureae involucratae medicinal granules and preparation method thereof
09/22/2010CN101837034A Method for extracting radix achyranthis bidentatae saponin
09/22/2010CN101837032A Blueberry anthocyanin oral solution
09/22/2010CN101837005A Process for preparing pig placenta extract
09/22/2010CN101836965A Orally disintegrating tablet containing fexofenadine or salts of fexofenadine, and preparation method thereof
09/22/2010CN101347436B Uses of methylprednisolone and derivatives thereof in preparing medicament for treating allergic rhinitis
09/22/2010CN101194968B Traditional Chinese medicine preparation for treating urticaria
09/22/2010CN101181626B Transfer factor capsule and preparation method thereof
09/22/2010CN101181612B Medicament for curing cold urticaria
09/21/2010US7799924 Substituted homopiperidine, piperidine or pyrrolidine derivatives
09/21/2010US7799827 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
09/21/2010US7799775 Pyrimidine derivatives
09/21/2010US7799762 Functionally substituted amino acids, having fatty acid chains bound through amidification of the amine functional groups of dipeptide like compounds, one end bears a functional side chain and other side neutral or charged acid
09/21/2010US7799755 Stimulating a Th2 response by administering multivalent LNFPIII, an immunomodulatory glycan Lacto-N-Fucopentaose III, which contains the Lewis X trisaccharide (CD!%/antigen/); autoimmune disease; antidiabetic agents; antiarthritic agents; multiple sclerosis; colitis; psoriasis
09/21/2010US7799350 Treating peripherial blood mononuclear cells with a suppressive composition for a time sufficient to induce T cell tolerance; and introducing said cells to said patient.
09/21/2010CA2440559C Novel non-imidazole compounds
09/21/2010CA2436225C N-(arylsulphonyl)beta-amino acid derivatives comprising a substituted aminomethyl group, process for preparing them and pharmaceutical compositions containing them
09/21/2010CA2434178C Substituted amine derivatives and methods of use
09/21/2010CA2420568C Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
09/21/2010CA2417148C Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
09/21/2010CA2401502C Carboxylic acid derivatives as ip antagonists
09/21/2010CA2369292C Method of modulating the activity of functional immune molecules
09/21/2010CA2343074C Akt nucleic acids, polypeptides, and uses thereof
09/21/2010CA2307142C N-terminally chemically modified protein compositions and methods
09/21/2010CA2306692C Dipeptide apoptosis inhibitors and the use thereof
09/21/2010CA2234941C Delivery of biologically active polypeptides
09/21/2010CA2225788C Therapeutic agents and autoimmune diseases
09/16/2010WO2010104961A1 Treatment methods for autoimmune disorders
09/16/2010WO2010104959A1 Treatment and diagnostic methods for hypersensitive disorders
1 ... 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 ... 1172